Laddar...
A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
ABSTRACT: Oral semaglutide (Rybelsus(®)) is a glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA) with 94% homology to human GLP-1. It is the first GLP-1RA developed for oral administration, and it comprises a co-formulation of the peptide semaglutide with the absorption enhancer sodium N-(8-...
Sparad:
| I publikationen: | Drugs |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer International Publishing
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8217049/ https://ncbi.nlm.nih.gov/pubmed/33964002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01499-w |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|